Is there a real difference in severity of tardive dyskinesia between risperidone and olanzapine?
Takefumi
T
Suzuki
Hiroyoshi
H
Takeuchi
Koichiro
K
Watanabe
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009069:Movement Disorders / Q000209:etiology*; D000077152:Olanzapine; D011618:Psychotic Disorders / Q000188:drug therapy; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D012720:Severity of Illness Index
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine